93 related articles for article (PubMed ID: 30452622)
1. ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
Ni H; Chen L; Song L; Sun L; Cui H; Zhou Q; Hu C; Jiao W; Shen T; Gao T; Liu Y; Li J
Carcinogenesis; 2019 Jul; 40(5):680-686. PubMed ID: 30452622
[TBL] [Abstract][Full Text] [Related]
2. ERBB4 acts as a suppressor in the development of hepatocellular carcinoma.
Liu Y; Song L; Ni H; Sun L; Jiao W; Chen L; Zhou Q; Shen T; Cui H; Gao T; Li J
Carcinogenesis; 2017 Apr; 38(4):465-473. PubMed ID: 28334319
[TBL] [Abstract][Full Text] [Related]
3. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
[TBL] [Abstract][Full Text] [Related]
4. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
5. ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation.
Schumacher MA; Hedl M; Abraham C; Bernard JK; Lozano PR; Hsieh JJ; Almohazey D; Bucar EB; Punit S; Dempsey PJ; Frey MR
Cell Death Dis; 2017 Feb; 8(2):e2622. PubMed ID: 28230865
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.
Liu Y; Zhou Q; He XS; Song LM; Chen L; Jiao WJ; Shen T; Yao S; Wu H; Hu ZB; Gao TM; Li JM
Oncotarget; 2016 Jan; 7(4):4981-92. PubMed ID: 26701850
[TBL] [Abstract][Full Text] [Related]
7. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF.
Frey MR; Edelblum KL; Mullane MT; Liang D; Polk DB
Gastroenterology; 2009 Jan; 136(1):217-26. PubMed ID: 18973758
[TBL] [Abstract][Full Text] [Related]
8. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses.
Hayakawa Y; Hirata Y; Nakagawa H; Sakamoto K; Hikiba Y; Otsuka M; Ijichi H; Ikenoue T; Tateishi K; Akanuma M; Ogura K; Yoshida H; Ichijo H; Omata M; Maeda S
Gastroenterology; 2010 Mar; 138(3):1055-67.e1-4. PubMed ID: 19931259
[TBL] [Abstract][Full Text] [Related]
10. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model.
Liu Y; Fang X; Yuan J; Sun Z; Li C; Li R; Li L; Zhu C; Wan R; Guo R; Jin L; Li S
Endocr Relat Cancer; 2014 Aug; 21(4):639-51. PubMed ID: 25015995
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
13. Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Hahm KB
Int J Cancer; 2016 Mar; 138(6):1482-93. PubMed ID: 26476372
[TBL] [Abstract][Full Text] [Related]
14. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
15. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
[TBL] [Abstract][Full Text] [Related]
16. Murine Model for Colitis-Associated Cancer of the Colon.
Snider AJ; Bialkowska AB; Ghaleb AM; Yang VW; Obeid LM; Hannun YA
Methods Mol Biol; 2016; 1438():245-54. PubMed ID: 27150094
[TBL] [Abstract][Full Text] [Related]
17. NRG4-ErbB4 signaling represses proinflammatory macrophage activity.
Schumacher MA; Dennis IC; Liu CY; Robinson C; Shang J; Bernard JK; Washington MK; Polk DB; Frey MR
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G990-G1001. PubMed ID: 33826403
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice.
Qi H; Yang H; Xu G; Ren J; Hua W; Shi Y; Torsvik M; Florholmen J; Cui G
Immunobiology; 2015 Jan; 220(1):54-9. PubMed ID: 25239511
[TBL] [Abstract][Full Text] [Related]
19. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.
He J; Shin H; Wei X; Kadegowda AK; Chen R; Xie SK
BMC Cancer; 2015 Mar; 15():189. PubMed ID: 25881076
[TBL] [Abstract][Full Text] [Related]
20. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
Xu J; Gong L; Qian Z; Song G; Liu J
Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
